Electron-capture GLC determination of timolol in human plasma and urine.
A GLC procedure was developed for measuring nanogram quantities of timolol in plasma and urine. The unchanged drug was extracted into heptane-4% isoamyl alcohol from alkalinized plasma or urine, together with a homolog of timolol which served as the internal standard. The compounds were subsequently back-extracted into 0.1 N HC1 and then into chloroform following adjustment of the acid phase to an alkaline pH. The compounds in the chloroform extract were derivatized with heptafluorobutyrylimidazole to form the diheptafluorobutyryl derivatives; these were quantitated by electron-capture GLC. Recovery of timolol added to normal plasma and urine was quantitative and reproducible, and no interfering substances were observed in normal biological samples. The method is capable of measuring concentrations as low as 2 ng/ml in plasma or 20 ng/ml in urine. After a 10-mg oral dose of 14C-timolol, peak plasma levels of approximately 30 ng/ml were ovserved in 1-2 hr.